Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression
Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression
The purpose of this study is to examine the effectiveness of ethyl-eicosapentanoic acid
 (ethyl-EPA), an omega-3 fatty acid, in treating depression.
Evidence suggests that omega-3 fatty acids may help reduce symptoms of depression. This study
 will determine whether ethyl-EPA, an omega-3 fatty acid, can be used safely and effectively
 to treat major depression.

 Participants will be randomly assigned to receive either ethyl EPA-containing pills or
 placebo daily for 8 weeks. Each week, participants will be asked to complete questionnaires
 which will be used to assess the severity of their depression.
Inclusion Criteria:

 -  Major depressive disorder

 Exclusion Criteria:

 -  Serious comorbid psychiatric disorder

 -  Unstable medical illness

 -  Prior use of any omega-3 fatty acid product